BioAtla, Inc.
BCAB- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826892
No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding BioAtla, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 97 | 4 | 80 | −13 |
| Shares | 25.5M | 48.8K | 23.5M | −1.97M (−7.7%) |
| Value | $127.7M | $244.0K | $67.1M | −$60.4M (−47.3%) |
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held BioAtla, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 1,031,805 | $2.94M | 0.08% |
| Healthcare of Ontario Pension Plan Trust Fund | 427,500 | $1.22M | 0.01% |
| Laurion Capital Management LP | 292,600 | $834.0K | 0.03% |
| Oasis Management Co Ltd. | 289,855 | $826.0K | 0.15% |
| Acadian Asset Management LLC | 152,497 | $435.0K | 0.00% |
| Toroso Investments, LLC | 129,511 | $369.0K | 0.01% |
| Formidable Asset Management, LLC | 72,087 | $205.0K | 0.05% |
| Newtyn Management, LLC | 65,332 | $186.0K | 0.04% |
| Cornercap Investment Counsel Inc | 47,396 | $135.0K | 0.02% |
| AQR Capital Management LLC | 34,126 | $97.0K | 0.00% |
| Rinkey Investments | 23,410 | $76.0K | 0.07% |
| Prelude Capital Management, LLC | 15,820 | $45.0K | 0.00% |
| Commonwealth Equity Services, LLC | 14,000 | $39.0K | 0.00% |
| HighTower Advisors, LLC | 13,000 | $37.0K | 0.00% |
| Boothbay Fund Management, LLC | 12,500 | $36.0K | 0.00% |
| Sawtooth Solutions, LLC | 10,045 | $29.0K | 0.00% |
| Private Advisor Group, LLC | 10,290 | $29.0K | 0.00% |
| Crewe Advisors LLC | 345 | $1.00K | 0.00% |
Sold out (31)
Institutions that held BioAtla, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (4)
Institutions that held BioAtla, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 27,022 | $135.0K |
| Virginia Retirement Systems Et Al | 14,200 | $71.0K |
| Teachers Retirement System of the State of Kentucky | 5,019 | $25.0K |
| Amalgamated Financial Corp. | 2,527 | $13.0K |